SS
ORTX

Steve Schonfeld’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Steve Schonfeld’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,860
Closed -$819K – 1299
2019
Q2 		$819K Buy
+5,860
New +$1.03M 0.03% 497

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Steve Schonfeld's ORTX Position: Q3 2019 in Review

Steve Schonfeld sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2019, closing a stake of 5,860 shares — an estimated $819K sold.

Steve Schonfeld first reported a position in ORTX in Q2 2019 and held it in 1 quarter. The position peaked at $819K in Q2 2019. 62 funds tracked by Wall St. Rank hold ORTX as of Q3 2019.

  • Steve Schonfeld reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
  • Steve Schonfeld sold 5,860 Orchard Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $819K.
  • Steve Schonfeld first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 1 quarter.
  • Steve Schonfeld's Orchard Therapeutics plc American Depositary Shares position peaked at $819K in Q2 2019.
  • 62 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.